Skip to main content

Table 4 Treatment and dosimetry results

From: Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease

 

IBD

No IBD

p value

n

%

n

%

Radiation dose

     

 3500 cGy in 5 fractions

26

84

3139

75

0.46

 3625 cGy in 5 fractions

3

10

537

13

 

Whole pelvis

     

 2100 cGy in 3 fractions

1

3

422

10

 

 1950 cGy in 3 fractions

1

3

86

2

 

IBD Dosimetric parameters

Mean

Median

Range

Target coverage

   

 CTV VRx (%)

99

100

99–100

 PTV VRx (%)

97

97

95–100

IDL (%)

84

84

83–88

Max dose (cGy)

4200

4200

4118–4217

Rectum Max (cGy)

3800

3800

3604–3919

Rectum V37.8 (%)

0.1

0

0–0.3

V37.8 cc (cc)

0.04

0

0–0.2

Rectum V33.9 (%)

5.2

4.7

1–13

V33.9 cc (cc)

2.7

2

1–9

Rectum V29 (%)

15

15

6–25

V29 cc (cc)

7.7

6.3

3–18

Rectum V19.2 (%)

37

37

20–56

V19.2 cc (cc)

19

16

9–34

Rectum V36 (cc)

0.35

0.29

0.01–1

Large Bowel Max (cGy)

2600

2600

1239–3689

Small Bowel Max (cGy)

1100

1100

956–1224